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Insulin-like growth 
factor and sodium 
transport
Aldosterone regulates sodium 
absorption in the terminal segments 
of the nephron, the connecting and 
collecting tubules. Insulin has long 
been known to increase sodium 
absorption and to mediate these 
eff ects by a pathway that intersects 
with that of aldosterone at the level of 
Sgk, a kinase critical for aldosterone 
action. However, the question remains 
whether it is insulin or insulin-like 
growth factor that causes the eff ects, 
as these two hormones can bind 
and activate each other’s receptors. 
However, each hormone binds to the 
receptor of the other with an affi  nity 
that is 50 times lower than that with 
which it binds to its own receptor. As 
they report in this issue, Gonzalez-
Rodriguez et al. used a collecting 
tubule cell line that shows all the signs 
of diff erentiation and responding 
to physiological concentrations 
of aldosterone by increasing its 
transepithelial sodium transport, 
making it a useful model of the 
principal cell, the target cell for 
the three hormones. By studying a 
detailed concentration–response curve, 
they found that the results showed 
a response that is most compatible 
with occupation of the insulin-like 
growth factor receptor. Further, as 
with the insulin response, it appeared 
that phosphatidylinositol 3-kinase 
was involved in the eff ect and that the 
levels of Sgk were also increased in a 
manner similar to that of aldosterone. 
Th ese results add insulin-like growth 
factor as a potential new hormone that 
regulates sodium absorption in the 
kidney; it is now necessary to perform 
in vivo whole-animal studies to see 
under what conditions these studies are 
relevant. See page 116.
Genome-wide scans in 
diabetic nephropathy
Diabetic nephropathy clusters in 
families, raising the question of the 
importance of critical genetic factors 
in its causation. Th e modern method 
for gaining insight into genetic factors 
without any idea of where to look is 
to interrogate the whole genome. In 
this issue, Tryggvason and colleagues 
report the beginning of such a study. In 
a two-stage procedure, they searched 
for chromosomal loci that might 
contain genes that would predispose 
to nephropathy in patients with type 
1 diabetes. Finland is a genetically 
homogenous country, and, hence, 
population studies there have the 
potential to uncover genetic causes of 
diseases; indeed, the authors of this 
paper started the new revolution in 
renal genetics by identifying nephrin, 
whose mutation causes nephrotic 
syndrome of the Finnish type, and 
incidentally ushering in the modern 
study of podocyte molecular biology. 
Th ey studied sibs that are concordant 
for diabetes but discordant for 
nephropathy. Using markers with 
reasonable dispersion throughout 
the genome, they fi rst performed 
model calculations to determine 
what is needed to obtain statistical 
signifi cance. Five loci were identifi ed 
on chromosomes 3, 4, 9, 16, and 22. 
Th en the authors used more markers 
that surrounded these loci. Although 
none of the statistical analyses showed 
that these loci were defi nite enough to 
implicate genes in these regions, those 
in chromosome 3q reached a maximum 
score that was suffi  ciently high to 
warrant further studies to identify 
a potential susceptibility locus for 
diabetic nephropathy. See page 140.
Protein breakdown in 
uremia
It is well known that protein metabolism 
in chronic renal failure is abnormal. 
Patients on chronic hemodialysis 
show varying degrees of resistance to 
the anabolic eff ects of insulin. In this 
issue, Ikizler and colleagues continue 
their interesting studies on protein 
metabolism in renal failure by studying 
whole-body as well as skeletal muscle 
(that is, forearm) protein turnover with 
the use of 13C amino acid infusions. 
Th ey also studied insulin and glucose 
homeostasis using the insulin clamp 
method. Although diabetic patients 
were excluded from the study, the 
patients showed insulin resistance. 
More interestingly, aft er attempts to 
fi nd correlations between diff erent 
components of the studies, there was 
a remarkable association between 
insulin resistance and muscle protein 
breakdown. Th ese results open the 
way for interventional trials that would 
attempt to improve muscle catabolism 
in renal failure by correcting insulin 
resistance. See page 146.
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